Búsqueda de un proyecto

Búsqueda de un proyecto

Otra(s) opcion(es) de búsqueda

72 Resultado(s)

Proyectos de investigación

Mecanismos genéticos en el desarrollo del linfoma no-Hodgkin pediátrico en pacientes inmunocompetentes y con inmunodeficiencia primaria Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Institut d'Investigacions Biomèdiques August Pi i Sunyer

INFORM-Registry: INdividualized Therapy FOr Relapsed Malignancies in Childhood Deutsches Krebsforschungszentrum Klinische Kooperationseinheit Pädiatrische Onkologie

HARMONY: Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - AT Institution: Information not provided - AT

Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Non-hodgkin Lymphoma, or Small Lymphocytic Lymphoma UCLA - University of California - Los Angeles University of California - Los Angeles

Retrospective evaluation of treatment modalities and outcomes of patients with aggressive B-cell lymphoma at the CCCF Lymphoma Centre of the University Hospital Freiburg Universitätsklinikum Freiburg Klinik für Innere Medizin I - Hämatologie, Onkologie und Stammzelltransplantation

Survey on long-term survival in patients with lymphoma disease - a multicenter study on return to work and quality of life Klinikum Stuttgart - Katharinenhospital Klinik für Hämatologie, Onkologie und Palliativmedizin

Genetic and epigenetic characterization of chronic lymphocytic leukemia with translocations involving the immunoglobulin loci (SFB 1074: Experimental Models and Clinical Translation in Leukemia) Universitätsklinikum Ulm Institut für Humangenetik

Mechanisms of CLL progression and Richter transformation in patients with CLL treated with agents targeting BTK and BCL2 (SFB 1074: Experimental Models and Clinical Translation in Leukemia) Universitätsklinikum Ulm am Oberen Eselsberg Klinik für Innere Medizin III

TurbiCAR: UniCAR-based therapy of CD123-positive leukemias Institution: Information not provided - DE

The role of MALT1 in the molecular pathogenesis of mantle cell lymphoma Universitätsklinikum Münster Medizinische Klinik und Poliklinik A

Routine care of patients with Waldenstrom's disease treated between 2020 and 2021 in hematology practices in Germany - Waldenstrom 20/21 Institut für Versorgungsforschung in der Onkologie GbR Institut für Versorgungsforschung in der Onkologie

PNCLS: Peripheral blood T cell alterations and their prognostic role in newly diagnosed primary central nervous system lymphoma Universitätsklinikum Magdeburg A.ö.R Universitätsklinik für Hämatologie und Onkologie

ZEUS: Non-interventional Study to Assess the Safety Profile of Idelalisib in Patients With Refractory Follicular Lymphoma - AT Institution: Information not provided - AT

PASS MCL-005: A Non-interventional, Post-authorization Safety Study of Patients With Relapsed or Refractory Mantle Cell Lymphoma to Further Investigate and Characterize the Association of Lenalidomide With Tumor Flare Reaction and High Tumor Burden - AT Institution: Information not provided - AT

Registry study to assess the long-term safety of patients with B lymphocyte malignancies treated with tisagenlecleucel - AT Institution: Information not provided - AT

FLORA: Follicular Lymphoma Outcomes in Relapsed/Refractory Patients Treated With Systemic Therapy in a Real-World Assessment - AT Institution: Information not provided - AT

Christian Doppler Laboratory for Applied metabolomics Medizinische Universität Wien Klinische Abteilung für Nuklearmedizin

Christian Doppler Laboratory for Applied metabolomics Medizinische Universität Wien Klinisches Institut für Pathologie

Identificación de marcadores clínico-biológicos predictores de supervivencia en linfoma difuso de células B grandes tras terapia con células CAR-T Fundación del Instituto de Estudios de Ciencias de la Salud de Castilla y León

Caracterización de la heterogeneidad intratumoral de la macroglobulinemia de Waldenström: utilidad en el diagnóstico y tratamiento de los pacientes Fundación del Instituto de Estudios de Ciencias de la Salud de Castilla y León

Secuenciación de nueva generación no invasiva del gen de la inmunoglobulina tumoral en linfoma difuso de células B grandes (LDCBG) Hospital de la Santa Creu i Sant Pau Servicio de Hematología

Secuenciación de próxima generación no invasiva de la inmunoglobulina tumoral (IgNGS) en el linfoma difuso de células B grandes (DLBCL): implicaciones pronósticas y evaluación de la respuesta tumoral Hospital de la Santa Creu i Sant Pau Servicio de Hematología

Identificación temprana de pacientes con linfoma folicular con mal pronóstico combinando técnicas de EMR en biopsia líquida y PET/TC Instituto de Investigación Hospital 12 de Octubre Fundación para la Investigación Biomédica del Hospital Universitario 12 de Octubre

Desarrollo de modelos genómicos funcionales basados en cultivos 3D (organoides) para una medicina de precisión en linfomas B agresivos Instituto de Investigación Sanitaria Puerta de Hierro Fundación para la Investigación Biomédica del Hospital Puerta de Hierro

Hts enabled examination of drug combinations Institution: Information not provided - US

Rag and aid biology Institution: Information not provided - US

Establish a model of follicular lymphoma in the chick embryo to personalize the treatment decision CLCC Léon Bérard Cancérologie médicale - Cancers hématologiques

Positron Emission Tomography (PET)-Scan in the evaluation of high tumor burden follicular lymphoma Hôpitaux Universitaires Henri Mondor Service de médecine nucléaire

Dialogue between Follicular Helper T-cells (TFH) and B-lymphocytes: Impact on the origin and heterogeneity of TFH in the context of Follicular Lymphoma Centre de Physiopathologie de Toulouse Purpan Cellules présentatrices de l'Antigène et Réponses T CD4

Single-Cell Map of Immune and Lymphoma Cells in B-cell Non-Hodgkin's Lymphoma IUCT Oncopole - CLCC Institut Claudius Regaud Département d'oncologie médicale

Mixed Molecular Clinical Index (MMCI) in Diffuse Large B-cell Lymphoma (DLBCL) IRST - Istituto Scientifico Romagnolo per lo studio e la cura dei Tumori Dipartimento di Oncologia ed Ematologia Clinica e Sperimentale

Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies IRST - Istituto Scientifico Romagnolo per lo studio e la cura dei Tumori IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Burkitt's lymphoma: relevance to therapy and prevention. Study of therapies in mouse animal models Istituto Nazionale per la Ricerca sul Cancro - IST Oncologia Medica

Multi-center registry study on proton radiotherapy for mediastinal lymphomas Neurologische Universitätsklinik Heidelberg Klinik für Radioonkologie und Strahlentherapie

ORCHID: Outcomes in Patients With Relapse/Refractory Diffuse Large B-Cell Lymphoma Treated With Systemic Therapy From Real-World Experience - AT Institution: Information not provided - AT

Improving treatment for Epstein Barr Virus (EBV) induced cancer Sanford Research/University of South Dakota Cancer Biology Research Center

Discovery of genetic/epigenetic addictions in NOTCH2/KLF2-mutated lymphoma Istituto di Ricerca in Biomedicina Istituto oncologico di ricerca (IOR)

ERA-NET TRANSCAN: BRCAddict - BRCAness as a therapeutic target for solid high-risk childhood tumors Deutsches Krebsforschungszentrum KITZ - Hopp-Kindertumorzentrum Heidelberg

CancerEvo: Investigation of evolution in sporadic and tumor disposition syndrome-associated tumors Universitätsklinikum Augsburg II. Medizinische Klinik

PanCareSurPass: PanCare studies of the scale-up and implementation of the digital Survivorship Passport to improve people-centred care for childhood cancer survivors - AT Gesundheit Österreich GmbH

Christian Doppler Laboratory for Next Generation CAR-T Cells St. Anna Kinderkrebsforschung Children's Cancer Research Institute

Instand-NGS4P: Integrated and standardized NGS workflows for Personalised therapy - AT St. Anna Kinderkrebsforschung

Follow-up of Fertility in Young Adults Who Did or Did Not Store Testicular Tissue Before Gonadotoxic Treatment for Fertility Preservation Universitair Ziekenhuis Brussel Universitair Ziekenhuis Brussel (UZ Brussel)

Beyond the Genome: Transcriptome Based Diagnostics for Rare Diseases and Cancer Hospital for Sick Children, Research Institute

Evaluating utility and improving implementation of genomic sequencing for pediatric cancer patients in the diverse population and healthcare settings of Texas: the kidscanseq study Institution: Information not provided - US

Personalized whole body staging for children with cancer: a solution to the conundrum of long-term side effects from ct and pet/ct scans Institution: Information not provided - US

Project 1: optimization of therapeutic approaches for children with relapsed sarcomas using precision medicine. Institution: Information not provided - US

Modulating BMP axis to prevent muscle loss, dismantling of NMJ and denervation in cancer cachexia Venetian Institute of Molecular Medicine Fondazione per la ricerca Biomedica avanzata ONLUS

Modelos mecanísticos mediante Machine Learning para el descubrimiento de dianas terapéuticas y reposicionamiento de fármacos en Enfermedades Raras ISCIII - Instituto de Salud Carlos III Centro de Investigación Biomédica en Red de Enfermedades Raras

Proyectos de investigación multicéntricos

VITAL: development of optimised recombinant idiotypic vaccines for subset-specific immunotherapy of B cell lymphomas Centro di Riferimento Oncologico Unità di Bioimmunoterapia

NOVEL: Employing NGS technology for improved, non-invasive early detection, staging and prediction of progression in lymphoma patients San Raffaele Scientific Institute Unità di Ricerca Neoplasie Linfocitarie B

EUROPEAN LEUKEMIA NET: Strengthen and develop scientific and technological excellence in research and therapy of leukemia Universitätsklinikum Mannheim European Leukemia Net - Network Management Center

European Consortium for Waldenström's Macroglobulinemia Universitätsklinikum Ulm Institut für Experimentelle Tumorforschung

FIRE-CLL: Fighting Resistance in CLL (chronic lymphocytic leukemia) Leibniz Research Centre for Working Environment and Human Factors Department of Toxicology/Systems Toxicology

European Mantle Cell Lymphoma Network LMU Klinikum der Universität München - Campus Großhadern Europäisches Mantelzell Lymphom Netzwerk - Sekretariat

FIRE-CLL: Fighting Resistance in CLL (chronic lymphocytic leukemia) European Commission DG Research - Directorate General for Research

Genetic and cellular intratumor heterogeneity as predictor of chronic lymphocytic leukemia outcome and treatment resistance CLCC Institut Gustave Roussy Groupe TET2 et hématopoïèse normale et pathologique

GCH-CLL: Genetic and cellular intratumor heterogeneity as predictor of chronic lymphocytic leukemia outcome and treatment resistance CLCC Institut Gustave Roussy Groupe TET2 et hématopoïèse normale et pathologique

TORPEDO: Targeting Of Resistance in PEDiatric Oncology Institution: Information not provided - DE

ExPO-r-Net: European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment St. Anna Kinderkrebsforschung Children's Cancer Research Institute

TRANSCAN-2: Aligning national/regional translational cancer research programmes and activities Institution: Information not provided - IT

RARECARE: surveillance of rare cancers in Europe Fondazione IRCCS Istituto Nazionale dei Tumori S.S. di Epidemiologia Valutativa

EPOC: European paediatric oncology off-patent medicines consortium Northern Institute for Cancer Research, Medical School, Newcastle University Northern Institute for Cancer Research

CAMINEMS: Integrated Micro-Nano-Opto Fluidic systems for high-content diagnosis and studies of rare cancer cells Institut Curie Macromolécules et Microsystèmes en Biologie et en Medecine

Mecanismos genéticos en el desarrollo del linfoma no-Hodgkin pediátrico en pacientes inmunocompetentes y con inmunodeficiencia primaria
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)

Institut d'Investigacions Biomèdiques August Pi i Sunyer

INFORM-Registry: INdividualized Therapy FOr Relapsed Malignancies in Childhood
Deutsches Krebsforschungszentrum

Klinische Kooperationseinheit Pädiatrische Onkologie

HARMONY: Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - AT
Institution: Information not provided - AT

Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Non-hodgkin Lymphoma, or Small Lymphocytic Lymphoma
UCLA - University of California - Los Angeles

University of California - Los Angeles

Retrospective evaluation of treatment modalities and outcomes of patients with aggressive B-cell lymphoma at the CCCF Lymphoma Centre of the University Hospital Freiburg
Universitätsklinikum Freiburg

Klinik für Innere Medizin I - Hämatologie, Onkologie und Stammzelltransplantation

Survey on long-term survival in patients with lymphoma disease - a multicenter study on return to work and quality of life
Klinikum Stuttgart - Katharinenhospital

Klinik für Hämatologie, Onkologie und Palliativmedizin

Genetic and epigenetic characterization of chronic lymphocytic leukemia with translocations involving the immunoglobulin loci (SFB 1074: Experimental Models and Clinical Translation in Leukemia)
Universitätsklinikum Ulm

Institut für Humangenetik

Mechanisms of CLL progression and Richter transformation in patients with CLL treated with agents targeting BTK and BCL2 (SFB 1074: Experimental Models and Clinical Translation in Leukemia)
Universitätsklinikum Ulm am Oberen Eselsberg

Klinik für Innere Medizin III

TurbiCAR: UniCAR-based therapy of CD123-positive leukemias
Institution: Information not provided - DE

The role of MALT1 in the molecular pathogenesis of mantle cell lymphoma
Universitätsklinikum Münster

Medizinische Klinik und Poliklinik A

Routine care of patients with Waldenstrom's disease treated between 2020 and 2021 in hematology practices in Germany - Waldenstrom 20/21
Institut für Versorgungsforschung in der Onkologie GbR

Institut für Versorgungsforschung in der Onkologie

PNCLS: Peripheral blood T cell alterations and their prognostic role in newly diagnosed primary central nervous system lymphoma
Universitätsklinikum Magdeburg A.ö.R

Universitätsklinik für Hämatologie und Onkologie

ZEUS: Non-interventional Study to Assess the Safety Profile of Idelalisib in Patients With Refractory Follicular Lymphoma - AT
Institution: Information not provided - AT

PASS MCL-005: A Non-interventional, Post-authorization Safety Study of Patients With Relapsed or Refractory Mantle Cell Lymphoma to Further Investigate and Characterize the Association of Lenalidomide With Tumor Flare Reaction and High Tumor Burden - AT
Institution: Information not provided - AT

Registry study to assess the long-term safety of patients with B lymphocyte malignancies treated with tisagenlecleucel - AT
Institution: Information not provided - AT

FLORA: Follicular Lymphoma Outcomes in Relapsed/Refractory Patients Treated With Systemic Therapy in a Real-World Assessment - AT
Institution: Information not provided - AT

Christian Doppler Laboratory for Applied metabolomics
Medizinische Universität Wien

Klinische Abteilung für Nuklearmedizin

Christian Doppler Laboratory for Applied metabolomics
Medizinische Universität Wien

Klinisches Institut für Pathologie

Identificación de marcadores clínico-biológicos predictores de supervivencia en linfoma difuso de células B grandes tras terapia con células CAR-T
Fundación del Instituto de Estudios de Ciencias de la Salud de Castilla y León

Caracterización de la heterogeneidad intratumoral de la macroglobulinemia de Waldenström: utilidad en el diagnóstico y tratamiento de los pacientes
Fundación del Instituto de Estudios de Ciencias de la Salud de Castilla y León

Secuenciación de nueva generación no invasiva del gen de la inmunoglobulina tumoral en linfoma difuso de células B grandes (LDCBG)
Hospital de la Santa Creu i Sant Pau

Servicio de Hematología

Secuenciación de próxima generación no invasiva de la inmunoglobulina tumoral (IgNGS) en el linfoma difuso de células B grandes (DLBCL): implicaciones pronósticas y evaluación de la respuesta tumoral
Hospital de la Santa Creu i Sant Pau

Servicio de Hematología

Identificación temprana de pacientes con linfoma folicular con mal pronóstico combinando técnicas de EMR en biopsia líquida y PET/TC
Instituto de Investigación Hospital 12 de Octubre

Fundación para la Investigación Biomédica del Hospital Universitario 12 de Octubre

Desarrollo de modelos genómicos funcionales basados en cultivos 3D (organoides) para una medicina de precisión en linfomas B agresivos
Instituto de Investigación Sanitaria Puerta de Hierro

Fundación para la Investigación Biomédica del Hospital Puerta de Hierro

Hts enabled examination of drug combinations
Institution: Information not provided - US

Rag and aid biology
Institution: Information not provided - US

Establish a model of follicular lymphoma in the chick embryo to personalize the treatment decision
CLCC Léon Bérard

Cancérologie médicale - Cancers hématologiques

Positron Emission Tomography (PET)-Scan in the evaluation of high tumor burden follicular lymphoma
Hôpitaux Universitaires Henri Mondor

Service de médecine nucléaire

Dialogue between Follicular Helper T-cells (TFH) and B-lymphocytes: Impact on the origin and heterogeneity of TFH in the context of Follicular Lymphoma
Centre de Physiopathologie de Toulouse Purpan

Cellules présentatrices de l'Antigène et Réponses T CD4

Single-Cell Map of Immune and Lymphoma Cells in B-cell Non-Hodgkin's Lymphoma
IUCT Oncopole - CLCC Institut Claudius Regaud

Département d'oncologie médicale

Mixed Molecular Clinical Index (MMCI) in Diffuse Large B-cell Lymphoma (DLBCL)
IRST - Istituto Scientifico Romagnolo per lo studio e la cura dei Tumori

Dipartimento di Oncologia ed Ematologia Clinica e Sperimentale

Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies
IRST - Istituto Scientifico Romagnolo per lo studio e la cura dei Tumori

IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Burkitt's lymphoma: relevance to therapy and prevention. Study of therapies in mouse animal models
Istituto Nazionale per la Ricerca sul Cancro - IST

Oncologia Medica

Multi-center registry study on proton radiotherapy for mediastinal lymphomas
Neurologische Universitätsklinik Heidelberg

Klinik für Radioonkologie und Strahlentherapie

ORCHID: Outcomes in Patients With Relapse/Refractory Diffuse Large B-Cell Lymphoma Treated With Systemic Therapy From Real-World Experience - AT
Institution: Information not provided - AT

Improving treatment for Epstein Barr Virus (EBV) induced cancer
Sanford Research/University of South Dakota

Cancer Biology Research Center

Discovery of genetic/epigenetic addictions in NOTCH2/KLF2-mutated lymphoma
Istituto di Ricerca in Biomedicina

Istituto oncologico di ricerca (IOR)

ERA-NET TRANSCAN: BRCAddict - BRCAness as a therapeutic target for solid high-risk childhood tumors
Deutsches Krebsforschungszentrum

KITZ - Hopp-Kindertumorzentrum Heidelberg

CancerEvo: Investigation of evolution in sporadic and tumor disposition syndrome-associated tumors
Universitätsklinikum Augsburg

II. Medizinische Klinik

PanCareSurPass: PanCare studies of the scale-up and implementation of the digital Survivorship Passport to improve people-centred care for childhood cancer survivors - AT
Gesundheit Österreich GmbH

Christian Doppler Laboratory for Next Generation CAR-T Cells
St. Anna Kinderkrebsforschung

Children's Cancer Research Institute

Instand-NGS4P: Integrated and standardized NGS workflows for Personalised therapy - AT
St. Anna Kinderkrebsforschung

Follow-up of Fertility in Young Adults Who Did or Did Not Store Testicular Tissue Before Gonadotoxic Treatment for Fertility Preservation
Universitair Ziekenhuis Brussel

Universitair Ziekenhuis Brussel (UZ Brussel)

Beyond the Genome: Transcriptome Based Diagnostics for Rare Diseases and Cancer
Hospital for Sick Children, Research Institute

Evaluating utility and improving implementation of genomic sequencing for pediatric cancer patients in the diverse population and healthcare settings of Texas: the kidscanseq study
Institution: Information not provided - US

Personalized whole body staging for children with cancer: a solution to the conundrum of long-term side effects from ct and pet/ct scans
Institution: Information not provided - US

Project 1: optimization of therapeutic approaches for children with relapsed sarcomas using precision medicine.
Institution: Information not provided - US

Modulating BMP axis to prevent muscle loss, dismantling of NMJ and denervation in cancer cachexia
Venetian Institute of Molecular Medicine

Fondazione per la ricerca Biomedica avanzata ONLUS

Modelos mecanísticos mediante Machine Learning para el descubrimiento de dianas terapéuticas y reposicionamiento de fármacos en Enfermedades Raras
ISCIII - Instituto de Salud Carlos III

Centro de Investigación Biomédica en Red de Enfermedades Raras

VITAL: development of optimised recombinant idiotypic vaccines for subset-specific immunotherapy of B cell lymphomas

Centro di Riferimento Oncologico

Unità di Bioimmunoterapia

NOVEL: Employing NGS technology for improved, non-invasive early detection, staging and prediction of progression in lymphoma patients

San Raffaele Scientific Institute

Unità di Ricerca Neoplasie Linfocitarie B

EUROPEAN LEUKEMIA NET: Strengthen and develop scientific and technological excellence in research and therapy of leukemia

Universitätsklinikum Mannheim

European Leukemia Net - Network Management Center

European Consortium for Waldenström's Macroglobulinemia

Universitätsklinikum Ulm

Institut für Experimentelle Tumorforschung

FIRE-CLL: Fighting Resistance in CLL (chronic lymphocytic leukemia)

Leibniz Research Centre for Working Environment and Human Factors

Department of Toxicology/Systems Toxicology

European Mantle Cell Lymphoma Network

LMU Klinikum der Universität München - Campus Großhadern

Europäisches Mantelzell Lymphom Netzwerk - Sekretariat

FIRE-CLL: Fighting Resistance in CLL (chronic lymphocytic leukemia)

European Commission

DG Research - Directorate General for Research

Genetic and cellular intratumor heterogeneity as predictor of chronic lymphocytic leukemia outcome and treatment resistance

CLCC Institut Gustave Roussy

Groupe TET2 et hématopoïèse normale et pathologique

GCH-CLL: Genetic and cellular intratumor heterogeneity as predictor of chronic lymphocytic leukemia outcome and treatment resistance

CLCC Institut Gustave Roussy

Groupe TET2 et hématopoïèse normale et pathologique

TORPEDO: Targeting Of Resistance in PEDiatric Oncology

Institution: Information not provided - DE

ExPO-r-Net: European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment

St. Anna Kinderkrebsforschung

Children's Cancer Research Institute

TRANSCAN-2: Aligning national/regional translational cancer research programmes and activities

Institution: Information not provided - IT

RARECARE: surveillance of rare cancers in Europe

Fondazione IRCCS Istituto Nazionale dei Tumori

S.S. di Epidemiologia Valutativa

EPOC: European paediatric oncology off-patent medicines consortium

Northern Institute for Cancer Research, Medical School, Newcastle University

Northern Institute for Cancer Research

CAMINEMS: Integrated Micro-Nano-Opto Fluidic systems for high-content diagnosis and studies of rare cancer cells

Institut Curie

Macromolécules et Microsystèmes en Biologie et en Medecine